S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
MarketBeat Week in Review – 11/27 - 12/1
Mega merger in the works? Humana, Cigna explore big deal
New CBOE “special perk” helps traders target income every weekend (Ad)
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/1/2023
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
MarketBeat Week in Review – 11/27 - 12/1
Mega merger in the works? Humana, Cigna explore big deal
New CBOE “special perk” helps traders target income every weekend (Ad)
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/1/2023
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
MarketBeat Week in Review – 11/27 - 12/1
Mega merger in the works? Humana, Cigna explore big deal
New CBOE “special perk” helps traders target income every weekend (Ad)
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/1/2023
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
MarketBeat Week in Review – 11/27 - 12/1
Mega merger in the works? Humana, Cigna explore big deal
New CBOE “special perk” helps traders target income every weekend (Ad)
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/1/2023
US targets oil and natural gas industry's role in global warming with new rule on methane emissions

IM Cannabis Stock Price, News & Analysis (NASDAQ:IMCC)

$0.41
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
$0.39
$0.41
50-Day Range
$0.39
$0.69
52-Week Range
$0.37
$2.14
Volume
37,873 shs
Average Volume
23,513 shs
Market Capitalization
$5.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IM Cannabis MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of IM Cannabis in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.48) to ($0.18) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars


IMCC stock logo

About IM Cannabis Stock (NASDAQ:IMCC)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

IMCC Stock Price History

IMCC Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Preview: IM Cannabis's Earnings
IM Cannabis Provides an Update on Panaxia Transaction
RAFAEL GABAY ACQUIRES SECURITIES OF IM CANNABIS CORP.
OREN SHUSTER ACQUIRES SECURITIES OF IM CANNABIS CORP.
See More Headlines
Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/02/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/03/2024

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMCC
Fax
N/A
Employees
283
Year Founded
N/A

Profitability

Net Income
$-145,290,000.00
Pretax Margin
13.20%

Debt

Sales & Book Value

Annual Sales
$41.79 million
Book Value
$1.10 per share

Miscellaneous

Free Float
12,599,000
Market Cap
$5.50 million
Optionable
Not Optionable
Beta
0.82
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Marc Lustig M.B.A. (Age 49)
    M.Sc., Executive Chairman
    Comp: $204.65k
  • Mr. Oren Shuster
    CEO & Director
  • Mr. Richard Balla
    CEO & Director of German Operations – Adjupharm GmbH
  • Mr. Michael Ruscetta (Age 54)
    Chief Executive Officer of Trichome Financial Corp.
    Comp: $93.09k
  • Mr. Howard Steinberg C.F.A. (Age 58)
    Chief Executive Officer of TJAC & MYM
    Comp: $510.52k
  • Ms. Rinat Efrima (Age 46)
    Chief Executive Officer of IMC Holdings Ltd.
  • Mr. Uri Birenberg (Age 47)
    Chief Financial Officer
  • Advocate Michal Lebovitz Nissimov
    General Counsel
  • Mr. Itay Vago
    Executive Officer














IMCC Stock Analysis - Frequently Asked Questions

Should I buy or sell IM Cannabis stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IM Cannabis in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" IMCC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMCC, but not buy additional shares or sell existing shares.
View IMCC analyst ratings
or view top-rated stocks.

How have IMCC shares performed in 2023?

IM Cannabis' stock was trading at $0.9748 at the start of the year. Since then, IMCC stock has decreased by 57.8% and is now trading at $0.4110.
View the best growth stocks for 2023 here
.

Are investors shorting IM Cannabis?

IM Cannabis saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,700 shares, a drop of 89.2% from the October 31st total of 15,800 shares. Based on an average daily trading volume, of 63,400 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company's shares are sold short.
View IM Cannabis' Short Interest
.

When is IM Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024.
View our IMCC earnings forecast
.

When did IM Cannabis' stock split?

Shares of IM Cannabis reverse split before market open on Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are IM Cannabis' major shareholders?

IM Cannabis' stock is owned by many different retail and institutional investors. Top institutional investors include Lynwood Capital Management Inc. (4.85%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of IM Cannabis?

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IMCC) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -